Illumina cuts FY25 adjusted EPS view to $4.20-$4.30 from $4.50, consensus $4.46

Expects FY25 Core Illumina (ILMN) revenue to decline between (1%) and (3%) on a constant currency basis year over year, down from low single digit growth previously; Revenue outside of the Greater China region expected to grow between 0% and 2% in 2025 on a constant currency basis year over year and includes our estimate reflecting changes in the research funding environment as well as the projected benefit from pricing actions.